|
Volumn 28, Issue 16, 2010, Pages
|
Active surveillance for prostate cancer: Has the time finally come?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
PROSTATE SPECIFIC ANTIGEN;
CANCER EPIDEMIOLOGY;
CANCER INCIDENCE;
CANCER MORTALITY;
CANCER RADIOTHERAPY;
CANCER RISK;
CANCER SCREENING;
CANCER SURGERY;
CHRONIC LYMPHATIC LEUKEMIA;
COHORT ANALYSIS;
DIAGNOSTIC ERROR;
DISTRESS SYNDROME;
FEASIBILITY STUDY;
FOLLOW UP;
HUMAN;
LETTER;
PRIMARY TUMOR;
PRIORITY JOURNAL;
PROSTATE BIOPSY;
PROSTATE CANCER;
RISK ASSESSMENT;
RISK BENEFIT ANALYSIS;
VALIDITY;
BLOOD;
CANCER STAGING;
EARLY DIAGNOSIS;
MALE;
METHODOLOGY;
MONITORING;
MORTALITY;
NOTE;
OBSERVATION;
PATHOLOGY;
PROSTATE TUMOR;
SURVIVAL RATE;
TIME;
EARLY DETECTION OF CANCER;
FOLLOW-UP STUDIES;
HUMANS;
MALE;
MONITORING, PHYSIOLOGIC;
NEOPLASM STAGING;
OBSERVATION;
PROSTATE-SPECIFIC ANTIGEN;
PROSTATIC NEOPLASMS;
RISK ASSESSMENT;
SURVIVAL RATE;
TIME FACTORS;
|
EID: 77954928781
PISSN: 0732183X
EISSN: 15277755
Source Type: Journal
DOI: 10.1200/JCO.2010.28.1584 Document Type: Letter |
Times cited : (4)
|
References (10)
|